Document is current
Any future updates will be listed below
-
Authors
Brink, Geertruid J.
Groeneweg, Jolijn W.
Sickinghe, Ariane A.
Nijman, Hans W.
van Lonkhuijzen, Luc R.C.W.
Lok, Christianne A. R.
Piek, Jurgen M. J.
Roes, Eva Maria
de Kroon, Cornelis D.
Hofhuis, Ward
Jonges, Geertruida N.
Gort, Eelke H.
Witteveen, Petronella O.
Zweemer, Ronald P.
- License Information
-
More Information
Article History
Received: 20 December 2024
Accepted: 10 February 2025
First Online: 22 February 2025
Declarations
:
: A national multicenter prospective study was conducted and approved by the Medical Ethics Committee of the University Medical Centre Utrecht (UMCU METC 17–868) and by the institutional review boards of all participating centers. All patients provided written informed consent. The study was registered in the Dutch Trial Register under trial number NL63786.041.17, first registered on April 17, 2018 (). The study was conducted in accordance with the ethical principles of the Declaration of Helsinki.
: All patients provided written informed consent.
: J.M.J. Piek received grants of the Dutch Cancer society, the Catharina research fund and the INNOsign/OPZuid grant. C.D. de Kroon received grants from ZonMW, KWF, and ZorgInstituut, and occupies chair roles for the guideline committee on endometrial cancer and the working party gynecological oncology from the NVOG. The other authors declare no conflicts of interest.
